单位：[1]Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China[2]Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China临床科室神经内科神经内科首都医科大学附属北京友谊医院
第一作者单位：[1]Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China
通讯作者：
推荐引用方式(GB/T 7714)：
Wang Yan-Xiang,Liu Zhan-Dong,Bi Chong-Wen,et al.How can tricyclic sophoridinic derivatives be used as autophagy inhibitors for cancer treatments?[J].FUTURE MEDICINAL CHEMISTRY.2017,9(9):835-837.doi:10.4155/fmc-2017-0081.
APA：
Wang, Yan-Xiang,Liu, Zhan-Dong,Bi, Chong-Wen,Liu, Lu,Song, Dan-Qing&Deng, Hong-Bin.(2017).How can tricyclic sophoridinic derivatives be used as autophagy inhibitors for cancer treatments?.FUTURE MEDICINAL CHEMISTRY,9,(9)
MLA：
Wang, Yan-Xiang,et al."How can tricyclic sophoridinic derivatives be used as autophagy inhibitors for cancer treatments?".FUTURE MEDICINAL CHEMISTRY 9..9(2017):835-837
：